Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism LOXL2 inhibitors(Lysyl oxidase homolog 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H17F4N3O3 |
InChIKeyODGXXYXJORZPHE-ZIAGYGMSSA-N |
CAS Registry2098884-52-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Idiopathic Pulmonary Fibrosis | Phase 1 | - | - |